Literature DB >> 3374984

Histamine-induced airway obstruction in infancy: changes in oxygenation.

A Prendiville1, D L Maxwell, A Rose, M Silverman.   

Abstract

In seven recurrently wheezy infants who were found to be histamine-responsive during bronchial challenge, changes in oxygenation (by oximeter and transcutaneous PO2 electrode) and carbon dioxide tension (by transcutaneous PCO2 electrode) were concurrently measured. The histamine challenge consisted of doubling concentrations administered by nebulizer for 1 min at 5-min intervals, up to a maximum concentration of 8 g/L. The response was determined from maximum expiratory flow using a squeeze technique. Significant mean reductions in transcutaneous oxygen tension of 0.9 +/- 0.7 kPa and 1.5 +/- 0.9 kPa were seen respectively at half the provoking concentration and at the provoking concentration of histamine that caused a significant reduction in maximum expiratory flow rates. The reduction in oxygen saturation of 4.8 +/- 3% was also significant at the provoking concentration. No significant change in transcutaneous carbon dioxide tension was seen. These results suggest that acute histamine-induced airway obstruction causes significant ventilation/perfusion disturbance in wheezy infants. Oxygen monitoring should be performed during bronchial challenge tests in infancy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3374984     DOI: 10.1002/ppul.1950040308

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  2 in total

1.  Repeatability of lung function tests during methacholine challenge in wheezy infants.

Authors:  C Delacourt; M R Benoist; S Waernessyckle; P Rufin; J J Brouard; J de Blic; P Scheinmann
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

2.  Repeatability of methacholine challenge in asthmatic children measured by change in transcutaneous oxygen tension.

Authors:  S B Phagoo; N M Wilson; M Silverman
Journal:  Thorax       Date:  1992-10       Impact factor: 9.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.